Sandra Calman, MD

Sandra Calman, MD is an experienced medical professional with over 20 years of experience in clinical development, drug safety, and medical monitoring roles. She is currently the CEO and Founding Partner of Safety Physician Associates Corp, where she serves as a Global Safety Physician, Medical Monitor and Clinical Development Consultant.1

Professional Background

Dr. Calman has extensive experience in:

• Strategic clinical development
• Managing clinical research operations
• Leading products from development through FDA approval (NDAs and BLAs)
• Medical writing, including protocols, safety plans, investigator brochures, and clinical study reports
• Medical oversight of global and U.S. clinical trials across all phases (I-IV)
• SAE signal detection and labeling recommendations

Her core competencies include clinical research, medical monitoring, drug safety/pharmacovigilance, and all phases of clinical development.1

Education and Certifications

• MD from the University of Utah School of Medicine, graduating with honors2
• Board Certified physician2
• Member of the American Academy of Family Practice and American Academy of Dermatology2

Career Highlights

• CEO and Founding Partner at Safety Physician Associates Corp (2007-present)1
• Vice President and Chief Medical Officer at Isolagen, Inc. (2007)2
• Director of Clinical Development and Drug Safety at Scios (2005-2006)1
• Expert Witness for the Security and Exchange Commission (2013-2016)1

Throughout her career, Dr. Calman has worked with numerous pharmaceutical and biotechnology companies, providing expertise in clinical development, medical monitoring, and drug safety across various therapeutic areas.1